PARIS: Artificial heart maker Carmat , whose financial situation has been under pressure, said on Monday that it had completed a 7 million euro ($7.4 million) capital increase with several of its historical financial shareholders.

Heart diseases: Punjab CM decides to introduce ‘drip and shift’ approach

Carmat estimated it will nevertheless have to secure around 50 million euros ($52.6 million) in extra financing to cover its operations and investments until the end of October 2024.